BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed TECX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:b98d6473fa2f9bdfdac3@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261124
DTEND;VALUE=DATE:20261125
SUMMARY:TECX P2 readout (est.): A Study of TX000045 in Patients With Pulmon
 ary Hypertension Secondary to Heart Failure With Preserved Ejection Fracti
 on (the APEX Study)
DESCRIPTION:A Study of TX000045 in Patients With Pulmonary Hypertension Sec
 ondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)\
 nNCT06616974 | PHASE2 | ACTIVE_NOT_RECRUITING | sponsor: Tectonic Therapeu
 tic\nPrimary completion date (ESTIMATED)\; top-line results usually follow
  later.\nTicker TECX (confidence 0.9)\nSource: https://clinicaltrials.gov/
 study/NCT06616974\nScheduling/reference data from public records\; dates c
 an move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06616974
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
